U.S. Food and Drug Administration Center for Drug Evaluation and ResearchSkip navigation

CDER - Center for Drug Evaluation and Research Logo

Drug Information

CDER Home Site Information Comments and Feedback What's New CDER Navigation Bar

First-Time Generics - February 2002

  Generic Name Brand Name Approval Date
1 KETOPROFEN TABLETS 12.5 MG TABLETS AND CAPLETS ORUDIS KT TABLETS 2/7/02
2 AMPHETAMINE AND DEXTROAMPHETAMINE (MIXED SALTS) 5 MG (TOTAL), 10 MG (TOTAL), 20 MG (TOTAL) AND 30 MG (TOTAL) ADDERAL TABLETS 2/11/02
3 CEFUROXIME AXETIL TABLETS , USP 125 MG (BASE), 250 MG (BASE), AND 500 MG (BASE). CEFTIN TABLETS 2/15/02
4 FLUNISOLIDE NASAL SOLUTION, USP 0.025% (25 MCG/SPRAY), 200 METERED SPRAY CONTAINER NASALIDE NASAL SOLUTION 2/20/02
6 MEFLOQUINE HYDROCHLORIDE TABLETS 250 MG LARIAM TABLETS 2/20/02
7 IFOSFAMIDE INJECTION/MESNA INJECTION KIT 50 MG/ML (1 G/20 ML OR 3 G/60 ML), AND 100 MG/ML (1 G/10 ML), RESPECTIVELY IFEX/MESNEX KIT 2/26/02

totop.gif (1525 bytes) Back to Top   Back Back to Approvals

FDA/Center for Drug Evaluation and Research
Last Updated: April 25, 2006
Originator: OGC
HTML by PKS, TA